Measuring the return from pharmaceutical innovation 2016
Balancing the R&D equation
The seventh annual pharmaceutical innovation study, co-produced by the Deloitte Center for Health Solutions in the US and the UK, looks at the challenges the industry faces in generating returns from its R&D investments.
Health Care Current library
Weekly insights in the US health care industry
This weekly series explores breaking news and developments in the US health care industry; examines key issues facing life sciences and health care companies; and provides updates and insights on policy, regulatory, and legislative changes.
Facing the tidal wave
De-risking pharma and creating value for patients
The pharmaceutical industry is facing a ‘tidal wave’ of complex age and behaviour-related diseases creating increased economic, scientific and delivery risks. How can pharma companies evolve to overcome these obstacles?